Clinical Trials
18 trialsNCT02354547 2026-05-08
A Study of SGT-53 in Children With Refractory or Recurrent Solid Tumors
SynerGene Therapeutics, Inc.
Phase 1 Suspended
NCT04418167 2025-09-03
JSI-1187-01 Monotherapy and in Combination With Dabrafenib for Advanced Solid Tumors With MAPK Pathway Mutations
JS InnoPharm, LLC
Phase 1 Suspended
NCT03659669 2023-10-23
REVEAL
AbbVie
Suspended
NCT04091711 2021-09-20
Evaluation of ReX-C® System for Medication Adherence in Oncology Patients Taking Oral Oncolytics
Dosentrx Ltd.
Phase NA Suspended
NCT04683120 2021-06-30
Real-time Diagnosis and Visualization of Tumor Margins in Excised Breast Specimens Using Zenith FLIM Diagnostics
Laser LabCorp
Phase NA Suspended
NCT01562626 2021-05-12
Phase I/II Study of APS001F With Flucytosine and Maltose in Solid Tumors
Anaeropharma Science, Inc.
Phase 1/2 Suspended
NCT04001010 2021-02-05
SERENITY
Tetra Bio-Pharma
Phase 3 Suspended
NCT01627795 2018-04-18
Safety and Efficacy of Oshadi D and Oshadi R for Malignant Mesothelioma Treatment
Oshadi Drug Administration
Phase 1/2 Suspended
NCT01211691 2015-11-17
Study of KB004 in Subjects With Hematologic Malignancies (Myelodysplastic Syndrome, MDS, Myelofibrosis, MF)
Humanigen, Inc.
Phase 1/2 Suspended
NCT01604863 2012-11-01
A Study of HGS1036 in Combination With Chemotherapy in Subjects With Advanced Solid Malignancies
GlaxoSmithKline
Phase 1 Suspended
NCT00909558 2010-02-24
Safety and Effectiveness Study of Autologous Natural Killer and Natural Killer T Cells on Cancer
Envita Medical Center, Inc.
Phase 1 Suspended
NCT00523094 2009-06-16
Vibration Response Imaging (VRI) in Patients That Are Candidates for Undergoing Pulmonary Operation Procedure
Deep Breeze
Suspended
NCT00459823 2009-03-24
A Dose Escalation Study of E7107 Administered IV (Bolus) on Days 1, 8, and 15 Every 28 Days to Patients With Solid Tumours
Eisai Inc.
Phase 1 Suspended
NCT00827203 2009-03-09
A Safety Study to Determine the Maximum Tolerated Dose of Elesclomol Sodium in Patients With Solid Tumors
Synta Pharmaceuticals Corp.
Phase 1 Suspended
NCT00499499 2009-02-04
A Dose Escalation Study of E7107 Administered Intravenously on Days 1 and 8 Every 21 Days to Patients With Solid Tumors
Eisai Inc.
Phase 1 Suspended
NCT00264472 2008-12-15
A Study of 5 Fluorouracil and the Anti-Tumor Activity of ADH300004 and 5 Fluorouracil in Subjects With Incurable Solid Tumors
Adherex Technologies, Inc.
Phase 1 Suspended
NCT00460278 2008-06-04
Study of XL418 in Adults With Solid Tumors
Exelixis
Phase 1 Suspended
NCT00103623 2006-09-19
The Plenaxis® Experience Study
PRAECIS Pharmaceuticals Inc.
Phase 4 Suspended